Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-19T12:25:27.915Z Has data issue: false hasContentIssue false
  • English
  • Français

HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR INNOVATIVE MEDICAL DEVICES IN UNIVERSITY HOSPITALS AND THE ROLE OF HOSPITAL PHARMACISTS: LEARNING FROM INTERNATIONAL EXPERIENCE

Published online by Cambridge University Press:  20 March 2013

Nicolas Martelli ,
Anne-Sophie Lelong ,
Patrice Prognon  and
Judith Pineau
Nicolas Martelli
Affiliation:
Hôpital Européen Georges Pompidou, Pharmacy, Assistance Publique-Hôpitaux de Paris
Anne-Sophie Lelong
Affiliation:
Hôpital Européen Georges Pompidou, Pharmacy, Assistance Publique-Hôpitaux de Paris
Patrice Prognon
Affiliation:
Hôpital Européen Georges Pompidou, Pharmacy, Assistance Publique-Hôpitaux de Paris
Judith Pineau
Affiliation:
Hôpital Européen Georges Pompidou, Pharmacy, Assistance Publique-Hôpitaux de Paris
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: Several models of hospital-based health technology assessment (HTA) have been developed worldwide, for the introduction of innovative medical devices and support evidence-based decision making in hospitals. Two such models, the HTA unit and mini-HTA models, are widespread in university hospitals and involve various stakeholders. The purpose of this work was to highlight the potential role of hospital pharmacists in hospital-based HTA activities.

Methods: We searched for articles, reviews, and letters relating to hospital-based HTA, as defined by the Hospital-Based Health Technology Assessment Worldwide Surveypublished by the Health Technology Assessment International (HTAi) Society, in the Health Technology Assessment database, MEDLINE, EMBASE, and hospital pharmacyjournals.

Results: The number of university hospitals performing hospital-based HTA has increased since the 2008 Hospital-Based Health Technology Assessment Worldwide Survey. Our own experience and international findings show that hospital pharmacists already contribute to hospital-based HTA activities and have developed study interpretation skills and a knowledge of medical devices.

Conclusions: Promoting multidisciplinary approaches is one of the key success factors in hospital-based HTA. Hospital pharmacists occupy a position between hospital managers, clinicians, health economists, biomedical engineers, and patients and can provide a new perspective. In the future, hospital pharmacists are likely to become increasingly involved in hospital-based HTA activities.

Keywords

Hospital-based HTAMini-HTAMedical device
Type
POLICIES
Information
International Journal of Technology Assessment in Health Care , Volume 29 , Issue 2 , April 2013 , pp. 185 - 191
Copyright
Copyright © Cambridge University Press 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Drummond, MF, Schwartz, JS, Jönsson, B, et al.Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–258.CrossRefGoogle ScholarPubMed
2.Chase, D, Rosten, C, Turner, S, Hicks, N, Milne, R.Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts. Health Technol Assess. 2009;13:1–142.CrossRefGoogle ScholarPubMed
3.Cicchetti, A, Marchetti, M, Dibidino, R, Corio, M.Hospital based health technology assessment world-wide survey. Health Technology Assessment International, Hospital Based Health Technology Assessment Sub-Interest Group. 2008. http://www.htai.org/fileadmin/HTAi_Files/ISG/HospitalBasedHTA/2008Files/HospitalBasedHTAISGSurveyReport.pdf (accessed August 3, 2012).Google Scholar
4.Ehlers, L, Vestergaard, M, Kidholm, K, et al.Doing mini-health technology assessments in hospitals: A new concept of decision support in health care? Int J Technol Assess Health Care. 2006;22:295–301.CrossRefGoogle ScholarPubMed
5.McGill University. Technology Assessment Unit of the MUHC [Internet]. (updated June 19, 2012). http://www.mcgill.ca/tau/ (accessed August 3, 2012).Google Scholar
6.Gagnon, M-P, Lepage-Savary, D, Gagnon, J, et al.Introducing patient perspective in health technology assessment at the local level. BMC Health Serv Res. 2009;9:54.CrossRefGoogle ScholarPubMed
7.Juzwishin, D, Olmstead, D, Menon, D.Hospital-based technology assessment programmes: Two Canadian examples. World Hosp Health Serv. 1996;32:2–9.Google ScholarPubMed
8.European Association of Hospital Pharmacists. Hospital Pharmacies in the European Union. 2002. http://www.hope.be/05eventsandpublications/docpublications/63_hosppharma_eu/63_HosPharma_2002.pdf (accessed August 3, 2012).Google Scholar
9.Filippi, C, Berto, P, Fantelli, V, Fratucello, A, Scroccaro, G, Marini, P.Report on the experience of application of HTA methodology to the medical device by UVEF (Veneto, Italy). Giornale Italiano di Farmacia Clinica. 2009;23:107–117. Italian.Google Scholar
10.Scroccaro, G.Clinical pharmacy in Italy. An increasing role in health technology assessment. Eur J Hosp Pharm. 2004;6:92.Google Scholar
11.Bodeau-Livinec, F, Simon, E, Montagnier-Petrissans, C, Joël, M-E, Féry-Lemonnier, E.Impact of CEDIT recommendations: An example of health technology assessment in a hospital network. Int J Technol Assess Health Care. 2006;22:161–168.CrossRefGoogle Scholar
12.Castoro, M.HTA and cross border cooperation: Promoting factors, barriers, challenges and future perspectives. The experience of Veneto region and Padova University Hospital. Euregio II Meeting 19th-20th of May 2010. (updated October 28, 2011). http://www.maastrichtuniversity.nl/web/Institutes/FHML/FHML/DepartmentsCAPHRI/InternationalHealth/ResearchINTHEALTH/Projects/EUREGIOII/PresentationsOfTheProject.htm (accessed August 3, 2012).Google Scholar
13.Favaretti, C, Cicchetti, A, Guarrera, G, Marchetti, M, Ricciardi, W.Health technology assessment in Italy. Int J Technol Assess Health Care. 2009;25 (Suppl S1):127–133.CrossRefGoogle ScholarPubMed
14.Horn, E, Jacobi, J.The critical care clinical pharmacist: Evolution of an essential team member. Crit Care Med. 2006;34 (Suppl):S46–S51.CrossRefGoogle ScholarPubMed
15.Bremberg, ER, Hising, C, Nylén, U, Ehrsson, H, Eksborg, S.An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract. 2006;12:75–81.CrossRefGoogle Scholar
16.Chisholm-Burns, MA, Kim Lee, J, Spivey, CA, et al.US pharmacists’ effect as team members on patient care: Systematic review and meta-analyses. Med Care. 2010;48:923–933.CrossRefGoogle ScholarPubMed
17.Gallego, G, Fowler, S, van Gool, K.Decision makers’ perceptions of health technology decision making and priority setting at the institutional level. Aust Health Rev. 2008;32:520–527.CrossRefGoogle ScholarPubMed
18.World Health Organization. Health technology assessment of medical devices. WHO Medical device technical series [Internet]. 2011. http://whqlibdoc.who.int/publications/2011/9789241501361_eng.pdf (accessed August 3, 2012).Google Scholar
19.Battista, RN, Côté, B, Hodge, MJ, Husereau, D.Health technology assessment in Canada. Int J Technol Assess Health Care. 2009;25 (Suppl S1):53–60.CrossRefGoogle ScholarPubMed
20.Cicchetti, A, Francesconi, A, Guizzetti, G, Lago, P, Maccarini, E.The development of hospital based HTA: The experience of five italian hospitals. 3rd Annual Meeting of Health Technology Assessment International (HTAi), Adelaide, South Australia, July 2006. Handb Health Technol Assess. 2006;3:51.Google Scholar
21.Zamora, A.Innovation policies development in the hospital sector & technology transfer process. Barcelona, Spain. 2009. www.biocat.cat/docs/FClinic_AZamora_IPRegulatory_090505.pdf (accessed August 3, 2012).Google Scholar
22.Catananti, C, Cicchetti, A, Marchetti, M.Hospital-based health technology assessment: The experience of Agostino Gemelli University Hospital's HTA Unit. Ital J Public Health. 2005;3.Google Scholar
23.Auer, R, Rodondi, N, Wasserfallen, J-B, Aujesky, D, Cornuz, J.[Cost-effectiveness analyses: What doctors should know]. Rev Med Suisse. 2009 25;5:2402, 2404–8. French.Google Scholar
24.Stahl, JE.Modelling methods for pharmacoeconomics and health technology assessment: An overview and guide. Pharmacoeconomics. 2008;26:131–148.CrossRefGoogle ScholarPubMed
25.Mitchell, MD, Williams, K, Brennan, PJ, Umscheid, CA.Integrating local data into hospital-based healthcare technology assessment: Two case studies. Int J Technol Assess Health Care. 2010;26:294–300.CrossRefGoogle ScholarPubMed
Supplementary material: File

Martelli et al. supplementary material

Supplementary table

Download Martelli et al. supplementary material(File)
File 31.2 KB